Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Early-onset Lafora body disease is an extremely rare, inherited form of progressive myoclonic epilepsy characterized by progressive myoclonus epilepsy and Lafora bodies, with an early onset (at around 5 years) and a prolonged disease course. Other manifestations include progressive dysarthria, ataxia, cognitive decline, psychosis, dementia, spasticity, dysarthria, myoclonus, and ataxia. The disease course typically extends for several decades.
Features include very common findings: Lafora bodies and Sudden, brief involuntary muscle jerks (myoclonus); and common findings: Dysarthria, Overactive reflexes (hyperreflexia), and Atypical behavior. 22 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 19 | Mutism, Spastic tetraplegia, Generalized myoclonic seizure |
PRDM8 function has not been fully characterized.
Early-onset Lafora body disease is associated with mutations in the PRDM8 gene on chromosome 4.
Genetic testing for PRDM8 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for early-onset Lafora body disease has been reported in the published literature.
Phenotype severity distribution: 2 very common features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for early-onset Lafora body disease.
25 publications have been identified in PubMed for early-onset Lafora body disease. Research spans Case Report / Case Series (52%), Review / Meta-Analysis (13%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 12 | 52% |
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:11 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Kidneys and urinary system |
1 |
Urinary incontinence |
Research summaries
3 |
13% |
Disease patterns and progression | 3 | 13% |
Laboratory research | 2 | 9% |
Testing and diagnosis research | 1 | 4% |
Clinical study results | 1 | 4% |
New treatment approaches | 1 | 4% |
Boespflug-Tanguy O (2026). [PMID: 42198847](https://pubmed.ncbi.nlm.nih.gov/42198847/). *Mol Ther*. [Gene Therapy / Novel Therapeutics]
Nishi E (2026). [PMID: 41479428](https://pubmed.ncbi.nlm.nih.gov/41479428/). *Clinical case reports*. [Case Report / Case Series]
Liu K (2026). [PMID: 41986128](https://pubmed.ncbi.nlm.nih.gov/41986128/). *Zhonghua Yi Xue Za Zhi*. [Case Report / Case Series]
Akçimen F (2025). [PMID: 40751262](https://pubmed.ncbi.nlm.nih.gov/40751262/). *Movement disorders : official journal of the Movement Disorder Society*. [Case Report / Case Series]
Invernizzi F (2025). [PMID: 39718800](https://pubmed.ncbi.nlm.nih.gov/39718800/). *Epilepsia open*. [Case Report / Case Series]
Talarico M (2025). [PMID: 39707840](https://pubmed.ncbi.nlm.nih.gov/39707840/). *Genetics in medicine : official journal of the American College of Medical Genetics*. [Case Report / Case Series]
Harisankar K (2025). [PMID: 38981679](https://pubmed.ncbi.nlm.nih.gov/38981679/). *Practical neurology*. [Case Report / Case Series]
Bai J (2025). [PMID: 40629380](https://pubmed.ncbi.nlm.nih.gov/40629380/). *Italian journal of pediatrics*. [Basic Science / Preclinical]
Maaz J (2025). [PMID: 40718525](https://pubmed.ncbi.nlm.nih.gov/40718525/). *Oxford medical case reports*. [Case Report / Case Series]
Andrade DM (2025). [PMID: 40956029](https://pubmed.ncbi.nlm.nih.gov/40956029/). *Epilepsia*. [Case Report / Case Series]
AI-curated news mentioning early-onset Lafora body disease
Updated Feb 25, 2026
Azeza Kasham raises awareness for Lafora disease after her sons Hiatham and Gigi were diagnosed, with Hiatham passing away in 2019. This fatal condition affects roughly 1 in 10 million people, leading to a life expectancy of only 10 years post-diagnosis.